SunHydrogen Narrows Loss to $1.56M Amid Soaring R&D Spend

TL;DR

**HYSR is burning cash on R&D with minimal revenue, making it a high-risk, long-shot bet on future green hydrogen tech.**

AI Summary

SunHydrogen, Inc. (HYSR) reported a net loss of $1,559,778 for the three months ended September 30, 2025, a significant improvement from the $2,046,838 net loss in the same period last year. Revenue from services, related party, increased from $0 in Q3 2024 to $1,250 in Q3 2025. However, total operating expenses surged to $1,924,395, up from $1,036,427, primarily driven by a substantial increase in research and development costs to $1,198,719 from $608,005. General and administrative expenses also rose to $705,977 from $418,744. The company's cash and cash equivalents decreased to $33,465,159 from $34,628,625 at June 30, 2025. Strategic outlook includes continued development of both nanoparticle-based and thin-film solar cell methodologies for green hydrogen production. Key risks include significant cash burn from R&D and reliance on investment income, which decreased to $377,170 from $479,723 year-over-year.

Why It Matters

For investors, HYSR's continued net losses and substantial R&D expenditures signal a long path to profitability, despite a narrowed loss. The increased R&D spend, nearly doubling to $1.2 million, indicates a strong commitment to technology development, which could be a competitive differentiator in the burgeoning green hydrogen market. However, the minimal revenue of $1,250 highlights the early-stage nature of their commercialization efforts. Employees are likely focused on R&D milestones, while potential customers await a viable, scalable product. The broader market will watch if HYSR can translate its R&D into a competitive green hydrogen solution against established and emerging players.

Risk Assessment

Risk Level: high — The company reported a net loss of $1,559,778 for the quarter and an accumulated deficit of $101,638,328, indicating a history of unprofitability. Cash and cash equivalents decreased by $1,163,466 during the quarter, and the company has a cash balance in excess of FDIC limits of $31,837,838, exposing it to significant credit risk.

Analyst Insight

Investors should approach HYSR with extreme caution, recognizing it as a highly speculative investment in early-stage technology. Monitor R&D progress closely for tangible breakthroughs and signs of commercialization, as the current financials show significant cash burn without substantial revenue generation. Consider the long-term potential of green hydrogen but be prepared for continued volatility and potential dilution.

Financial Highlights

debt To Equity

0.02

revenue

$1,250

operating Margin

-196,312.24%

total Assets

$35,735,409

total Debt

$766,842

net Income

$-1,559,778

eps

N/A

gross Margin

N/A

cash Position

$33,465,159

revenue Growth

N/A

Revenue Breakdown

Key Numbers

• $1,559,778 — Net Loss (For the three months ended September 30, 2025, an improvement from $2,046,838 in Q3 2024.)
• $1,250 — Revenue (From services, related party, for Q3 2025, up from $0 in Q3 2024.)
• $1,198,719 — Research and Development Cost (For Q3 2025, a significant increase from $608,005 in Q3 2024.)
• $33,465,159 — Cash and Cash Equivalents (As of September 30, 2025, down from $34,628,625 at June 30, 2025.)
• $101,638,328 — Accumulated Deficit (As of September 30, 2025, indicating historical losses.)
• 5,438,414,015 — Common Shares Outstanding (As of November 10, 2025.)
• $31,837,838 — Cash in Excess of FDIC Limits (As of September 30, 2025, representing concentration risk.)
• $377,170 — Investment Income (For Q3 2025, decreased from $479,723 in Q3 2024.)

Key Players & Entities

• SUNHYDROGEN, INC. (company) — Registrant
• Nevada (regulator) — State of incorporation
• BioVentures Center (company) — Principal executive offices location
• Coralville, IA (company) — Company base of operations
• SEC (regulator) — Filing oversight
• Bloomberg (company) — Publisher of analysis
• FDIC (regulator) — Federal Deposit Insurance Company

FAQ

Risk Factors

• High Cash Burn Rate [high — financial]: The company's operating expenses surged by 85.7% to $1,924,395 in Q3 2025 from $1,036,427 in Q3 2024. This was primarily driven by a 97.1% increase in R&D costs to $1,198,719 and a 68.6% increase in G&A expenses to $705,977, indicating a significant cash burn.
• Declining Investment Income [medium — financial]: Investment income decreased by 21.3% to $377,170 in Q3 2025 from $479,723 in Q3 2024. This reliance on investment income, which is declining, poses a risk to the company's ability to fund its operations.
• Low Cash Reserves [medium — financial]: Cash and cash equivalents decreased to $33,465,159 as of September 30, 2025, from $34,628,625 at June 30, 2025. With a high burn rate, the current cash position may not be sustainable without further financing.
• Accumulated Deficit [high — financial]: The company has an accumulated deficit of $101,638,328 as of September 30, 2025, highlighting a history of losses and the need for significant future profitability.
• Dependence on R&D Success [high — operational]: The substantial increase in R&D expenses to $1,198,719 is tied to the development of nanoparticle-based and thin-film solar cell methodologies. The success of these technologies is critical for future revenue generation.
• Concentration Risk in Cash Holdings [low — financial]: Cash in excess of FDIC limits was $31,837,838 as of September 30, 2025. This represents a significant portion of the company's cash and exposes it to counterparty risk if the financial institution holding these funds were to fail.

Industry Context

SunHydrogen is operating in the nascent green hydrogen production sector, which is experiencing significant investment and technological development. The industry is characterized by a race to develop cost-effective and scalable production methods, including advanced solar-based technologies. Key competitors are also focusing on R&D to improve efficiency and reduce production costs.

Regulatory Implications

While the 10-Q does not detail specific regulatory hurdles, companies in the green energy sector often face evolving environmental regulations and compliance requirements. Government incentives and policies related to renewable energy and hydrogen production can significantly impact the industry's growth and SunHydrogen's financial performance.

What Investors Should Do

1. Monitor R&D progress closely: The substantial investment in R&D is the primary driver of future growth. Investors should track milestones and technological advancements.
2. Evaluate cash burn rate: The significant increase in operating expenses, particularly R&D, necessitates careful monitoring of the company's cash runway and potential need for future funding.
3. Assess the sustainability of investment income: The decline in investment income highlights the need for the company to generate operational revenue to offset expenses.
4. Understand related party transactions: The minimal revenue from related parties should be scrutinized for its strategic importance and potential conflicts of interest.

Glossary

Accumulated deficit

The total net losses of a company over its lifetime that have not been offset by profits or capital contributions. (Indicates the company's historical unprofitability, with a deficit of $101,638,328 as of September 30, 2025.)

Related party

A transaction or relationship between two parties that are connected by ownership, control, or a significant influence. (Revenue of $1,250 was generated from services provided to a related party in Q3 2025.)

Short-term investments

Investments that are expected to be converted into cash within one year. (Decreased from $2,997,460 on June 30, 2025, to $1,978,096 on September 30, 2025.)

Depreciation and amortization

The systematic allocation of the cost of tangible assets (depreciation) and intangible assets (amortization) over their useful lives. (Total depreciation and amortization expense was $10,203 for Q3 2025.)

Preferred Stock, subject to redemption

A class of stock that has priority over common stock in dividend payments and asset distribution, and which the company is obligated to redeem at a future date or upon certain events. (The company has Series C Preferred Stock with a redeemable value of $516,500 as of September 30, 2025.)

Year-Over-Year Comparison

Compared to the prior year's third quarter, SunHydrogen reported a reduced net loss of $1,559,778 versus $2,046,838. However, this improvement was overshadowed by a substantial increase in operating expenses, which nearly doubled to $1,924,395, driven by a near doubling of R&D costs. Revenue remains negligible, with only $1,250 from related party services. Cash reserves saw a slight decrease, and investment income declined, underscoring the company's continued reliance on external funding and the high cost of its development efforts.

Filing Documents

• ea0264163-10q_sunhydro.htm (10-Q) — 437KB
• ea026416301ex31-1_sunhydro.htm (EX-31.1) — 11KB
• ea026416301ex32-1_sunhydro.htm (EX-32.1) — 4KB
• 0001213900-25-108125.txt ( ) — 4000KB
• hysr-20250930.xsd (EX-101.SCH) — 36KB
• hysr-20250930_cal.xml (EX-101.CAL) — 31KB
• hysr-20250930_def.xml (EX-101.DEF) — 211KB
• hysr-20250930_lab.xml (EX-101.LAB) — 389KB
• hysr-20250930_pre.xml (EX-101.PRE) — 227KB
• ea0264163-10q_sunhydro_htm.xml (XML) — 369KB

: FINANCIAL INFORMATION

PART I: FINANCIAL INFORMATION 1 Item 1:

Financial Statements (Unaudited)

Financial Statements (Unaudited) 1 Condensed Balance Sheets 1 Condensed Statements of Operations 2 Condensed Statements of Shareholders' Equity/(Deficit) 3 Condensed Statements of Cash Flows 4 Notes to the Condensed Financial Statements 5 Item 2:

Management's Discussion and Analysis of Financial Condition and

Management's Discussion and Analysis of Financial Condition and Results of Operations 16 Item 3:

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 19 Item 4:

Controls and Procedures

Controls and Procedures 19

: OTHER INFORMATION

PART II: OTHER INFORMATION 20 Item 1

Legal Proceedings

Legal Proceedings 20 Item 1A:

Risk Factors

Risk Factors 20 Item 2: Unregistered Sales of Equity Securities and Use of Proceeds 20 Item 3: Defaults Upon Senior Securities 20 Item 4: Mine Safety Disclosures 20 Item 5: Other Information 20 Item 6: Exhibits 20

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements. SUNHYDROGEN, INC. CONDENSED BALANCE SHEETS September 30, June 30, 2025 2025 (unaudited) ASSETS CURRENT ASSETS Cash and cash equivalents $ 33,465,159 $ 34,628,625 Accounts receivable, related party 1,250 - Prepaid expenses 70,035 72,313 Interest receivable 30,773 25,223 Short-term investments 1,978,096 2,997,460 TOTAL CURRENT ASSETS 35,545,313 37,723,621 OTHER ASSETS PROPERTY & EQUIPMENT Machinery and equipment 36,830 36,830 Vehicle 152,260 152,260 189,090 189,090 Less: accumulated depreciation ( 49,194 ) ( 40,660 ) NET PROPERTY AND EQUIPMENT 139,896 148,430 INTANGIBLE ASSETS Trademark, net of amortization of $ 971 and $ 942 , respectively 171 200 Patents, net of amortization of $ 51,114 and $ 49,474 , respectively 50,029 51,669 TOTAL INTANGIBLE ASSETS 50,200 51,869 TOTAL OTHER ASSETS 190,096 200,299 TOTAL ASSETS $ 35,735,409 $ 37,923,920 LIABILITIES, PREFERRED STOCK SUBJECT TO REDEMPTION AND SHAREHOLDERS' DEFICIT CURRENT LIABILITIES Accounts payable and other payables $ 668,148 $ 527,619 Accrued expenses 98,694 147,323 TOTAL LIABILITIES 766,842 674,942 COMMIMENTS AND CONTINGENCIES - - Series C 10 % Preferred Stock, 5,165 and 6,651 shares issued and outstanding, redeemable value of $ 516,500 and $ 665,100 , respectively 516,500 665,100 SHAREHOLDERS' EQUITY Preferred Stock, $ 0.001 par value; 5,000,000 authorized preferred shares - - Common Stock, $ 0.001 par value; 10,000,000,000 authorized common shares 5,438,414,015 shares issued and outstanding, respectively 5,438,414 5,438,414 Additional Paid in Capital 130,651,981 131,224,014 Accumulated deficit ( 101,638,328 ) ( 100,078,550 ) TOTAL SHAREHOLDERS' EQUITY 34,452,067 36,583,878 TOTAL LIABILITIES, PREFERRED STOCK SUBJECT TO REDEEMPTION AND SHAREHOLDERS' EQUITY $ 35,735,409 $ 37,923,920 The accompanying notes are an integral part of these unaudited condens

View Full Filing

View this 10-Q filing on SEC EDGAR